PH-sensitive polymeric micelles for programmable drug and gene delivery

Current Pharmaceutical Design

Volumn 18, Issue 23, 2012, Pages 3442-3451

  Liu, Zhihong ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Acid degradable linkages; Biomedical applications; PH sensitive building blocks; PH sensitive polymeric micelles; Programmable drug and gene delivery

Indexed keywords

ACETAL DERIVATIVE; ACRYLIC ACID; CAMPTOTHECIN; CANDESARTAN HEXETIL; COPOLYMER; DOXORUBICIN; DRUG CARRIER; FENOFIBRATE; HISTIDINE; HYDRAZONE DERIVATIVE; IBUPROFEN; MACROGOL; OXIME DERIVATIVE; PACLITAXEL; POLYACRYLIC ACID; POLYCAPROLACTONE; POLYHISTIDINE; POLYLACTIDE; POLYLYSINE; POLYMERIC MICELLE; POLYMETHACRYLIC ACID; PROGESTERONE; SMALL INTERFERING RNA; SULFONAMIDE; UNCLASSIFIED DRUG;

DRUG RELEASE; GENE TARGETING; HYDROPHILICITY; HYDROPHOBICITY; MOLECULAR SIZE; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; PRIORITY JOURNAL; PROTON TRANSPORT; REVIEW; TRANSMISSION ELECTRON MICROSCOPY;

DRUG CARRIERS; GENETIC VECTORS; HUMANS; HYDROGEN-ION CONCENTRATION; MICELLES; POLYMERS; TRANSFECTION;

EID: 84863522336     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212801227122     Document Type: Review

References (82)

1. Croy SR, Kwon GS. Polymeric micelles for drug delivery. Curr Pharm Des 2006; 12: 4669-4684.
2. Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006; 112: 630-648.
3. Liu J, Lee H, Allen C. Formulation of drugs in block copolymer micelles: drug loading and release. Curr Pharm Des 2006; 12: 4685-4701.
4. Yokoyama M. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials. Expert Opin Drug Deliv 2010; 7: 145-158.
5. Miyata K, Christie RJ, Kataoka K. Polymeric micelles for nanoscale drug delivery. React Funct Polym 2011; 71: 227-234.
6. Matsumura Y. Preclinical and clinical studies of anticancer drugincorporated polymeric micelles. J Drug Target 2007; 15: 507-517.
7. Matsumura Y, Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci 2009; 100: 572-579.
8. Matsumura Y, Hamaguchi T, Ura T, et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 2004; 91: 1775-1781.
9. Matsumura Y. Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect. Adv Drug Deliv Rev 2011; 63: 184-192.
10. Soga O, van Nostrum CF, Fens M, et al. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J Control Release 2005; 103: 341-353.
11. Wei H, Chen WQ, Chang C, et al. Synthesis of star block, thermosensitive poly(L-lactide)-star block-poly(N-isopropylacrylamide-co-N-hydroxymethylacrylamide) copolymers and their selfassembled micelles for controlled release. J Phys Chem C 2008; 112: 2888-2894.
12. Oh KT, Kim D, You HH, Ahn YS, Lee ES. pH-sensitive properties of surface charge-switched multifunctional polymeric micelle. Int J Pharm 2009; 376: 134-140.
13. Yin HQ, Bae YH. Physicochemical aspects of doxorubicin-loaded pH-sensitive polymeric micelle formulations from a mixture of poly(L-histidine)-b-poly(L-lactide)-b-poly(ethylene glycol). Eur J Pharm Biopharm 2009; 71: 223-230.
14. Husseini GA, Pitt WG. The use of ultrasound and micelles in cancer treatment. J Nanosci Nanotechnol 2008; 8: 2205-2215.
15. Zhang HJ, Xia HS, Wang J, Li YW. High intensity focused ultrasound-responsive release behavior of PLA-b-PEG copolymer micelles. J Control Release 2009; 139: 31-39.
16. Wang J, Pelletier M, Zhang HJ, Xia HS, Zhao Y. High-frequency ultrasound-responsive block copolymer micelle. Langmuir 2009; 25: 13201-13205.
17. Engin K, Leeper DB, Cater JR, Thistlethwaite AJ, Tupchong L, McFarlane JD. Extracellular pH distribution in human tumours. Int J Hyperthermia 1995; 11: 211-216.
18. Daugherty AL, Mrsny RJ. Transcellular uptake mechanisms of the intestinal epithelial barrier-Part one. Pharm Sci Technolo Today 1999; 2: 144-151.
19. Rajput G, Majmudar F, Patel J, Thakor R, Rajgor NB. Stomachspecific mucoadhesive microsphere as a controlled drug delivery system. Syst Rev Pharm 2010; 1: 70-8.
20. Wallmark B, Larsson H, Humble L. The relationship between gastric acid secretion and gastric H+, K+-ATPase activity. J Biol Chem 1985; 260: 13681-13684.
21. Wikberg M, Ulmius J, Ragnarsson G. Targeted drug delivery in treatment of intestinal diseases. Aliment Pharmacol Ther 1997; 11: 109-115.
22. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035-1041.
23. McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 2008; 364: 213-226.
24. Gerweck LE. The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer. Drug Resist Updat 2000; 3: 49-50.
25. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 2004; 14: 198-206.
26. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989; 49: 4373-4384.
27. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996; 56: 1194-1198.
28. Parks SK, Chiche J, Pouyssegur J. pH control mechanisms of tumor survival and growth. J Cell Physiol 2011; 226: 299-308.
29. Adams DJ, Morgan LR. Tumor physiology and charge dynamics of anticancer drugs: implications for camptothecin-based drug development. Curr Med Chem 2011; 18: 1367-72.
30. Teicher BA, Song CW, Griffin R, Park HJ. Influence of tumor pH on therapeutic response. Cancer Drug Resistance; Humana Press 2006; 21-42.
31. Tredan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 2007; 99: 1441-1454.
32. Zhang X, Lin Y, Gillies RJ. Tumor pH and its measurement.J Nucl Med 2010; 51: 1167-1170.
33. Lee ES, Oh KT, Kim D, Youn YS, Bae YH. Tumor pH-responsive flower-like micelles of poly(L-lactic acid)-b-poly (ethylene glycol)-b-poly(L-histidine). J Control Release 2007; 123: 19-26.
34. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett 2005; 5: 325-329.
35. Lee ES, Gao ZG, Kim D, Park K, Kwon IC, Bae YH. Super pHsensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. J Control Release 2008; 129: 228-236.
36. Oh KT, Lee ES. Cancer-associated pH-responsive tetracopolymeric micelles composed of poly(ethylene glycol)-b-poly(L-histidine)-bpoly(L-lactic acid)-b-poly(ethylene glycol). Polym Adv Technol 2008; 19: 1907-1913.
37. Kim D, Lee ES, Oh KT, Gao ZG, Bae YH. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. Small 2008; 4: 2043-2050.
38. Kim D, Lee ES, Park K, Kwon IC, Bae YH. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. Pharm Res 2008; 25: 2074-2082.
39. Gao ZG, Tian L, Hu J, Park IS, Bae YH. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles. J Control Release 2011; 152: 84-89.
40. Liu R, Li D, He B, et al. Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles. J Control Release 2011; 152: 49-56.
41. Ko J, Park K, Kim YS, et al. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (beta-amino ester) block copolymer micelles for cancer therapy. J Control Release 2007; 123: 109-115.
42. Min KH, Kim JH, Bae SM, et al. Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy. J Control Release 2010; 144: 259-266.
43. Wu XL, Kim JH, Koo H, et al. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. Bioconjug Chem 2010; 21: 208-213.
44. Sethuraman VA, Lee MC, Bae YH. A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm Res 2008; 25: 657-666.
45. Sethuraman VA, Bae YH. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 2007; 118: 216-224.
46. Sant VP, Smith D, Leroux JC. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. J Control Release 2004; 97: 301-312.
47. Sant VP, Smith D, Leroux JC. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-blockpoly(alkyl acrylate-co-methacrylic acid) self-assemblies. J Control Release 2005; 104: 289-300.
48. Satturwar P, Eddine MN, Ravenelle F, Leroux JC. pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth) acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil. Eur J Pharm Biopharm 2007; 65: 379-387.
49. Kim S, Kim JY, Huh KM, Acharya G, Park K. Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel. J Control Release 2008; 132: 222-229.
50. Yang YQ, Zheng LS, Guo XD, Qian Y, Zhang LJ. pH-sensitive micelles self-assembled from amphiphilic copolymer brush for delivery of poorly water-soluble drugs. Biomacromolecules 2011; 12: 116-122.
51. Bae Y, Fukushima S, Harada A, Kataoka K. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew Chem Int Ed Engl 2003; 42: 4640-4643.
52. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 2005; 16:122-130.
53. Bae Y, Jang WD, Nishiyama N, Fukushima S, Kataoka K. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol Biosyst 2005; 1: 242-250.
54. Bae Y, Alani AWG, Rockich NC, Lai TSZC, Kwon GS. Mixed pH-sensitive polymeric micelles for combination drug delivery. Pharm Res 2010; 27: 2421-2432.
55. Alani AWG, Bae Y, Rao DA, Kwon GS. Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel. Biomaterials 2010; 31: 1765-1772.
56. Hruby M, Konak C, Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Control Release 2005; 103: 137-148.
57. Kim JK, Garripelli VK, Jeong UH, Park JS, Repka MA, Jo S. Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery. Int J Pharm 2010; 401: 79-86.
58. Liu J, Li HX, Jiang XQ, Zhang C, Ping QN. Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel. Carbohydr Polym 2010; 82: 432-439.
59. Jin Y, Song L, Su Y, et al. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers. Biomacromolecules 2011; 12: 3460-3468.
60. Lee ES, Shin HJ, Na K, Bae YH. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release 2003; 90: 363-374.
61. Pack DW, Putnam D, Langer R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol Bioeng 2000; 67: 217-223.
62. Lee ES, Na K, Bae YH. Polymeric micelle for tumor pH and folate-mediated targeting. J Control Release 2003; 91: 103-113.
63. Mohajer G, Lee ES, Bae YH. Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells. Pharm Res 2007; 24: 1618-1627.
64. Kim MS, Hwang SJ, Han JK, et al. pH-responsive PEG-poly(betaamino ester) block copolymer micelles with a sharp transition. Macromol Rapid Commun 2006; 27:447-451.
65. Lynn DM, Langer R. Degradable poly(beta-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 2000; 122: 10761-10768.
66. Akinc A, Anderson DG, Lynn DM, Langer R. Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery. Bioconjug Chem 2003; 14: 979-988.
67. Han SK, Na K, Bae YH. Sulfonamide based pH-sensitive polymeric micelles: physicochemical characteristics and pH-dependent aggregation. Colloids Surf A Physicochem Eng Asp 2003; 214: 49-59.
68. Kang SI, Bae YH. pH-induced solubility transition of sulfonamidebased polymers. J Control Release 2002; 80: 145-155.
69. Xue YN, Huang ZZ, Zhang JT, et al. Synthesis and self-assembly of amphiphilic poly(acrylic acid-b-DL-lactide) to form micelles for pH-responsive drug delivery. Polymer 2009; 50: 3706-3713.
70. Xu S, Luo Y, Haag R. Water-soluble pH-responsive dendritic coreshell nanocarriers for polar dyes based on poly(ethylene imine). Macromol Biosci 2007; 7: 968-974.
71. Ding CX, Gu JX, Qu XZ, Yang ZZ. Preparation of multifunctional drug carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker. Bioconjug Chem 2009; 20: 1163-1170.
72. Lu JM, Lu JS, Li NJ, Xu QF, Ge JF, Xia XW. Acetals moiety contained pH-sensitive amphiphilic copolymer self-assembly used for drug carrier. Polymer 2010; 51: 1709-1715.
73. Wagner E, Knorr V, Russ V, Allmendinger L, Ogris M. Acetal linked oligoethylenimines for use as pH-sensitive gene carriers. Bioconjug Chem 2008; 19:1625-1634.
74. Heller J, Barr J. Poly(ortho esters)-from concept to reality. Biomacromolecules 2004; 5: 1625-1632.
75. Carmona S, Jorgensen MR, Kolli S, et al. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. Mol Pharm 2009; 6: 706-717.
76. Paramonov SE, Bachelder EM, Beaudette TT, et al. Fully aciddegradable biocompatible polyacetal microparticles for drug delivery. Bioconjug Chem 2008; 19: 911-919.
77. Bachelder EM, Beaudette TT, Broaders KE, Dashe J, Frechet JMJ. Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. J Am Chem Soc 2008; 130: 10494-10495.
78. Rijcken CJ, Soga O, Hennink WE, van Nostrum CF. Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release 2007; 120: 131-148.
79. Friedmann T, Roblin R. Gene therapy for human genetic disease? Science 1972; 175: 949-955.
80. Oishi M, Nagatsugi F, Sasaki S, Nagasaki Y, Kataoka K. Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages. Chembiochem 2005; 6: 718-725.
81. Oishi M, Nagasaki Y, Itaka K, Nishiyama N, Kataoka K. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile ss-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc 2005; 127: 1624-1625.
82. Gao GH, Lee JW, Nguyen MK, et al. pH-responsive polymeric micelle based on PEG-poly(beta-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area. J Control Release 2011; 155: 11-7.